A detailed history of Viewpoint Investment Partners Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Viewpoint Investment Partners Corp holds 6,243 shares of ABBV stock, worth $1.17 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
6,243
Holding current value
$1.17 Million
% of portfolio
0.71%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 16, 2025

BUY
$169.2 - $216.66 $1.06 Million - $1.35 Million
6,243 New
6,243 $1.31 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $331B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Viewpoint Investment Partners Corp Portfolio

Follow Viewpoint Investment Partners Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Viewpoint Investment Partners Corp, based on Form 13F filings with the SEC.

News

Stay updated on Viewpoint Investment Partners Corp with notifications on news.